Phase 1 Long COVID Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your Body Mass Index (BMI) — a measure of body weight relative to height — must be between 18.5 and 32.0 (confirm with trial site for exact measurement)
Who may not be able to join:
- You have, or have had in the past, significant problems with your heart, lungs, liver, kidneys, stomach or digestive system, hormones, blood, nervous system, or eyes (such as high pressure in the eyes) that could affect how your body processes medicines or that could put you at risk during the study
- You have a history of cancer, unless it was a certain type of skin cancer that was fully removed with no signs of spread for at least 3 years
- You currently need to take any medication or follow any special treatment, such as a restricted diet or physical therapy
- You have taken part in another clinical research study, or are currently in one, within the last 30 days (or longer, depending on the study drug involved)
- You tested positive for hepatitis B, hepatitis C, or HIV at screening or within the 6 months before receiving the study treatment
- You test positive for COVID-19 (SARS-CoV-2) when you check in for any study visit
- You have a known allergy or sensitivity to any ingredient in the study drug or its placebo (dummy version)
- You have used cannabis, tobacco, or any nicotine-containing products — including e-cigarettes, pipes, cigars, chewing tobacco, nicotine patches, or nicotine gum — within the 6 months before joining the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 800-849-9707
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Part: Number of Participants With Treatment-emergent Adverse Events (TEAEs); Part 2: Number of Participants With TEAEs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.